N-Nitroso Fedratinib Impurity 1
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Fedratinib is used to treat adults with certain types of myelofibrosis (MF; a cancer of the bone marrow in which the bone marrow is replaced by scar tissue and causes decreased blood cell production). Fedratinib is in a class of medications called kinase inhibitors.N-Nitroso Fedratinib Impurity 1 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
N-Nitroso Fedratinib Impurity 1 CAS NO:NA Chemically represented as N-(Tert-butyl)-3-((5-methyl-2-(nitroso(4-(2-(pyrrolidin-1-yl)ethoxy)phenyl)amino)pyrimidin-4-yl) (nitroso) amino) benzenesulfonamide .Synchemia is the leading manufacturing and exporter of N-Nitroso Fedratinib Impurity 1.We supply N-Nitroso Fedratinib Impurity 1 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0144067 |
| CAS No | NA |
| Mol.F. | C16H21N3O |
| Mol.Wt. | 271.4 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0144068 |
| CAS No | NA |
| Mol.F. | C17H19N4O3S : Cl |
| Mol.Wt. | 359.4 : 35.5 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0144069 |
| CAS No | NA |
| Mol.F. | C14H17N3O |
| Mol.Wt. | 243.3 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0144070 |
| CAS No | NA |
| Mol.F. | C17H22N4O3S |
| Mol.Wt. | 362.4 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0144071 |
| CAS No | NA |
| Mol.F. | C17H19N4O3S : Cl |
| Mol.Wt. | 359.4 : 35.5 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0144072 |
| CAS No | NA |
| Mol.F. | C20H31N5O5S2 |
| Mol.Wt. | 485.6 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0144073 |
| CAS No | NA |
| Mol.F. | C20H26N5O5S2 : Cl |
| Mol.Wt. | 480.6 : 35.5 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0144074 |
| CAS No | NA |
| Mol.F. | C17H24N4O4S |
| Mol.Wt. | 380.46 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0144075 |
| CAS No | NA |
| Mol.F. | C18H24N4O5S |
| Mol.Wt. | 408.47g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0144076 |
| CAS No | NA |
| Mol.F. | C20H26N5O5S2 |
| Mol.Wt. | 480.58 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0144077 |
| CAS No | NA |
| Mol.F. | C20H30N4O5S2 |
| Mol.Wt. | 470.60g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0144078 |
| CAS No | NA |
| Mol.F. | C20H31N5O5S2 |
| Mol.Wt. | 485.62 /mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0144079 |
| CAS No | NA |
| Mol.F. | C17H22N4O3S |
| Mol.Wt. | 362.45 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0144080 |
| CAS No | NA |
| Mol.F. | C16H22N4O3S |
| Mol.Wt. | 350.44g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0144081 |
| CAS No | NA |
| Mol.F. | C19H30N4O5S |
| Mol.Wt. | 426.53 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |